financetom
Business
financetom
/
Business
/
Analyst Predicts Double-Digit Revenue Growth For Retail Brokers, Noting Weak M&A, ECM/DCM Volumes In Investment Banking Sector
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Analyst Predicts Double-Digit Revenue Growth For Retail Brokers, Noting Weak M&A, ECM/DCM Volumes In Investment Banking Sector
May 26, 2025 8:55 AM

Goldman Sachs analyst James Yaro discusses the performance of retail brokers and investment bank stocks in his coverage.

Retail Broker Sector: In particular, the analyst noted that Coinbase Global, Inc. ( COIN ) , Robinhood Markets, Inc. ( HOOD ) and Interactive Brokers Group, Inc. ( IBKR ) witnessed an average rise of about 35% since April 1, 2025, significantly outperforming the S&P 500 by 31 percentage points.

Yaro writes that this indicates ongoing optimism about the retail trading environment, supported by robust April metrics.

Also Read: Coinbase Hit By Data Breach, Refuses To Pay $20M Ransom

The analyst says he remains positive on retail trading, noting that current levels are still considerably below historical highs when adjusted for account growth.

Yaro estimates 12%/5% revenue and EPS CAGRs from 2024-2027, driven by robust account acquisition, strong assets gathering, and a cyclically supportive retail trading environment.

Yaro projects compound annual growth rates (CAGRs) of 12% for revenue and 5% for EPS from 2024 to 2027, based on strong new account acquisition, robust asset gathering, and a cyclically supportive retail trading environment.

Investment Bank Sector: Stocks are up 7% since the same date, slightly outperforming the S&P 500 by three percentage points, adds the analyst.

Yaro says that the cyclical recovery in investment banking appears to have been delayed again, with disclosed industry M&A fees down 34% quarter-to-date year-over-year and ECM/DCM volumes falling 44%/41% in April year-over-year.

The analyst adds that the market likely needs more concrete signs of an investment banking recovery for the stocks to continue outperforming from this point on.

Given the base case scenario of limited mergers and acquisitions activity this year, the analyst anticipates a modest 3% year-over-year increase in total revenue for 2025.

In the near term, the analyst’s model forecasts a 2% quarter-over-quarter revenue decline for the second quarter of 2025.

Nevertheless, Yaro maintains a positive outlook for the medium term, projecting revenue growth of 16% in 2026 and 10% in 2027.

Overall, he views companies with more consistent structural growth prospects as positive, including Buy-rated Houlihan Lokey, Inc. ( HLI ) , HOOD, and IBKR.

Yaro also favors companies with an underappreciated counter-cyclical business, such as our Buy-rated Evercore Inc. ( EVR ) , and companies with the potential to gain market share, which includes all four mentioned.

In particular, he anticipates a strong trading environment to support HOOD and IBKR, while HLI should experience through-the-cycle growth from ongoing momentum in Corporate Finance and benefits from restructuring and inorganic growth execution.

Yaro forecasts EVR to deliver best-in-class revenue growth from 2025 to 2027 and sees potential upside for EVR through its exposure to Equity Capital Markets (ECM).

Read Next:

Coinbase CEO Brian Armstrong Invites DOGE Staff To ‘Create A More Efficient Financial System’

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Italy investigates Sephora and Benefit Cosmetics over marketing to children
Italy investigates Sephora and Benefit Cosmetics over marketing to children
Mar 27, 2026
March 27 (Reuters) - The Italian competition authority AGCM has launched two investigations into LVMH-owned Sephora and Benefit Cosmetics over possible unfair commercial practices linked to the marketing of products for adults to children and adolescents, it said on Friday. AGCM said it was concerned the brands were using very young micro-influencers on social media to encourage premature use of...
Pbf Energy Insider Sold Shares Worth $3,149,950, According to a Recent SEC Filing
Pbf Energy Insider Sold Shares Worth $3,149,950, According to a Recent SEC Filing
Mar 27, 2026
04:20 AM EDT, 03/27/2026 (MT Newswires) -- Trecia M Canty, Senior Vice President and General Counsel, on March 24, 2026, sold 62,999 shares in Pbf Energy ( PBF ) for $3,149,950. Following the Form 4 filing with the SEC, Canty has control over a total of 191,779 Class A common shares of the company, with 191,779 shares held directly. SEC...
Klaviyo Insider Sold Shares Worth $3,634,000, According to a Recent SEC Filing
Klaviyo Insider Sold Shares Worth $3,634,000, According to a Recent SEC Filing
Mar 27, 2026
04:20 AM EDT, 03/27/2026 (MT Newswires) -- Andrew Bialecki, 10% Owner, Director, Co-Chief Executive Officer, on March 24, 2026, sold 200,000 Series A common shares in Klaviyo ( KVYO ) for $3,634,000. SEC Filing: https://www.sec.gov/Archives/edgar/data/1835830/000147083126000318/xslF345X05/wk-form4_1774569691.xml ...
Revolution Medicines Insider Sold Shares Worth $3,578,821, According to a Recent SEC Filing
Revolution Medicines Insider Sold Shares Worth $3,578,821, According to a Recent SEC Filing
Mar 27, 2026
04:20 AM EDT, 03/27/2026 (MT Newswires) -- Anthony Mancini, Chief Global Commercialization Officer, on March 25, 2026, sold 37,450 shares in Revolution Medicines ( RVMD ) for $3,578,821. Following the Form 4 filing with the SEC, Mancini has control over a total of 54,400 common shares of the company, with 54,400 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1628171/000161071726000137/xslF345X05/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved